Specifically, the sh-LAMP5-AS1 groups survived longer than the control groups (Fig. 2d), suggesting that the knockdown of LAMP5-AS1 could effectively inhibit the malignant progression of MLL leukemia. The gene discussed is LAMP5; the disease is leukemia.